Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation

Transplantation

Volumn 63, Issue 10, 1997, Pages 1521-1524

  Norris, Suzanne ^a   Crosbie, Orla ^a   McEntee, Gerry ^a   Traynor, Oscar ^a   Nolan, Niamh ^a   McCann, Sean ^b   Hegarty, John ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIINFECTIVE AGENT; ASPARAGINASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BUSULFAN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAUNORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; METHYLPREDNISOLONE; PENTAMIDINE; PREDNISOLONE; TACROLIMUS; TISSUE PLASMINOGEN ACTIVATOR; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE BIOPSY; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; GRAFT REJECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; VEIN OCCLUSION;

ADULT; BONE MARROW TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; THROMBOLYTIC THERAPY;

EID: 0030981164     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705270-00026     Document Type: Article

References (19)

1. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease-liver toxic syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197.
2. McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. The clinical course of 53 patients with veno-occlusive disease of the liver after marrow transplantation. Transplantation 1985; 39: 603.
3. Dulley FL, Kanfer EJ, Appelbaum FR, et al. Veno-occlusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 1987; 43: 870.
4. Jones RJ, Lee KSK, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778.
5. Rapport AP, Doyle HR, Starzl T, Rowe JM, Doeblin T, DiPersio JF. Orthotopic liver transplant for life threatening veno-occlusive disease of the liver after allogenic bone marrow transplantation. Bone Marrow Transpl 1991; 8: 421.
6. Nimer SD, Milewicz AL, Champlin RE, Busuttil RW. Successful treatment of hepatic veno-occlusive disease in a bone marrow transplant patient with orthotopic liver transplantation. Transplantation 1990; 49: 819.
7. Bunin N, Leahey A, Dunn S. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation. Transplantation 1996; 61: 664.
8. Meresse W, Hartmann O, Vassal G, et al. Risk factors for hepatic veno-occlusive disease after high dose busulphan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135.
9. Essell JH, Thompson JM, Harman GS, et al. Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide. Blood 1992; 79: 2784.
10. McDonald GB, Hinds M, Fischer L, Schoch HG. Liver toxicity following cytoreductive therapy for marrow transplantation: risk factors, incidence and outcome [Abstract]. Hepatology 1991; 14: 162a.
11. Carreras E, Grariera A, Navasa M, et al. Transjugular liver biopsy in bone marrow transplantation. Bone Marrow Transplant 1993; 21.
12. Bearman SI, Mori M, Hinds MS, McDonald GB. A statistical model to predict unfavorable outcome in patients with veno-occlusive disease of the liver after bone marrow transplantation. Exp Hematol 1990; 18: 699.
13. Attal M, Hugurt F, Rubie H, et al. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial. Blood 1992; 79: 2834.
14. Bearman SI, Hinds MS, Wolford JL, et al. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation. Bone Marrow Transplant 1990; 5: 407.
15. 1 for prevention of liver venoocclusive disease in leukaemic patients treated by allogenic bone marrow transplantation. Br J Haematol 1990; 74: 277.
16. 1 for prevention of hepatic veno-occlusive disease: results of phase I study. Exp Haematol 1991; 19: 567.
17. Bianco JA, Appelbaum FR, Nemunaitis J, et al. Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation. Blood 1991; 78: 1205.
18. Baglin TP, Harper P, Marcus RE. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplant 1990; 5: 439.
19. U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.